Lab (Specimen)

Conventional Units

SI Units

Acetylcholinesterase (RBC)
top of page
11,000 – 15,000 IU/L 11-15 kIU/L
Acid Phosphatase Prostatic (Immunoassay) Serum
top of page
0.0-3.5 ng/mL 0.0-3.5 ng/mL
Acid Phosphatase, Total, Serum (Enzymatic)
top of page
0.0-4.3 U/L 0.0-4.3 U/L
Adrenocorticotropic Hormone (ACTH) (Plasma).  Immunoassay top of page (<70 pg/mL).
Male and female:
1 week- 9 yrs: 5-46 pg/mL.
10 -18 yrs: 6-55 pg/mL.

Female: >/=19 yrs: 6 -58 pg/mL.
Male: >/=19 yrs: 7 -69 pg/mL

<15 pmol/L
Alanine Aminotransferase (ALT), Serum

Formerly “SGPT” [Serum glutamic pyruvic transaminase]
– Normal: 5 – 35 IU/dL.
– Found in heart, liver, and skeletal muscle.
– Much more specific marker of liver injury than AST.
top of page

Males 0 – 35 U/L;
Females 0 – 20 U/L
Males 0 – 35 U/L;
Females 0 – 20 U/L
Albumin (Serum)
top of page
3.5 – 5 g/dL 30 – 50 g/L
Aldosterone (Serum)
top of page
Age Posture Unspecified Supine Upright
0-6 days 5.0 – 102.0 ng/dL
1-3 weeks 6.0 -179.0 ng/dL
1-11 months 7.0 -99.0 ng/dL
1-2 years 7.0 -93.0 ng/dL
3-10 years 4.0 -44.0 ng/dL
11-14 years 4.0 -31.0 ng/dL
15 years and older 31.0 ng/dL or less 16.0 ng/dL or less 4.0-31.0 ng/dL
Alkaline phosphatase Isoenzymes top of page
Male:
Serum or plasma:
0-30 days: 60-320 U/L
1-11 months: 70-350 U/L
1-3 years: 125-320 U/L
4-6 years: 150-370 U/L
7-9 years: 150-440 U/L
10-11 years: 150-470 U/L
12-13 years: 160-500 U/L
14-15 years: 130-530 U/L
16-19 years: 60-270 U/L
20 and older: 40-120 U/L
Bone:
1-6 years: 0-208 U/L
7-9 years: 0-264 U/L
10-15 years: 0-340 U/L
16-19 years: 0-165 U/L
20 and older:  0-55 U/L
Liver:
1-6 years: 0-145 U/L
7-11 years: 0-182 U/L
12-15 years: 0-226 U/L
16-19 years: 0-114 U/L
20+ years: 0-94 U/L
Female:
Serum or plasma:
0-30 days: 60-320 U/L
1-11 months: 70-350 U/L
1-3 years: 125-320 U/L
4-6 years: 150-370 U/L
7-9 years: 150-440 U/L
10-11 years: 150-530 U/L
12-13 years: 110-525 U/L
14-15 years: 55-305 U/L
16-19 years: 40-120 U/L
20 and older: 40-120 U/L
Bone:
1-6 years: 0-189 U/L
7-9 years: 0-246 U/L
10-13 years: 0-340 U/L
14-15 years: 0-91 U/L
16+ years: 0-55 U/L
Liver:
1-9 years: 0-148 U/L
10-15 years: 0-162 U/L
16+ years: 0-94 U/L
Ammonia, Plasma
top of page
0.17 – 0.80 µg/mL
Alt Source: 15-45 µg/dl
10 – 47 µmol/L
Alt source: 11-32 µmol/L
Amylase, Isoenzymes (Serum)

top of page

Component Reference Interval
Pancreatic amylase 18 months-6 years: 0-68 U/L
7-17 years: 9-39 U/L
18 years and older: 12-52 U/L
Salivary amylase 18 months and  older:  9-86 U/L
Total amylase 18 -35 months: 19-92 U/L
3 -4 years: 26-106 U/L
5-12 years: 30-119 U/L
13 years and older: 30-110 U/L

ALT:
35 -118 IU/L  (0.58 -1.97 mckat/L)

Anion Gap
Anti-Nuclear Antibody (ANA) Titer
top of page
(Negative) <1:40 Titer
Antithrombin III Activity (Plasma)

top of page

1-4 days: 39-87%
5-29 days: 41-93%
30-89 days: 48-108%
90-179 days: 73-121%
180-364 days: 84-124%
1-6 years: 82-139%
7-9 years: 96-135%
10-11 years: 92-134%
12-13 years: 92-128%
14-15 years: 95-135%
16-17 years: 94-131%
18 years and older: 76-128%
Normal reference range:
69 – 132%
Antithrombin ??? (AT ???)
top of page
80-120 U/dL 800-1200 U/L
Anti-Thyroglobulin Antibody Screen (Serum)   top of page <1.0 IU/mL < 1 kU/L
Alpha-1-Antitrypsin (Serum)
top of page
80-200 mg/dL 0.8 – 2.0 g/L
Arterial Blood Gases (ABGs)
Aspartate Aminotransferase (AST), Serum

– Formerly “SGOT”  [Serum glutamic oxaloacetic transaminase]
– Normal: 5 – 35 IU/dL.
– Found in heart, liver, and skeletal muscle.
– Not as specific a marker as ALT for liver injury.  top of page

(<42 U/L )
Males: 0 – 37 U/L
Females: 0 – 31 U/L
Using the AST/ALT ratio can help in differential diagnosis

– AST/ALT > 2 indicates chronic alcoholism.

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer